Overview
Vidya Seshadri is a Hematologist and an Oncologist in Bowling Green, Kentucky. Dr. Seshadri is rated as an Advanced provider by MediFind in the treatment of Chronic Lymphocytic Leukemia (CLL). Her top areas of expertise are Inflammatory Breast Cancer, Angiosarcoma, Familial Colorectal Cancer, and Lung Cancer.
Her clinical research consists of co-authoring 18 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
201 Park St, Bowling Green, KY 42101
Additional Areas of Focus
Dr. Seshadri has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Sarah Cannon Research Institute
Dr. Patel joined SCRI in 2024, as director of lymphoma research, and oversees SCRI’s comprehensive lymphoma clinical trial portfolio. Previously, he served as the Director of Hematologic Malignancies and Cell Therapy at the Swedish Cancer Institute in Seattle, Washington, where he led development of the program’s clinical standards for lymphoma care, assisted in the expansion of cell therapy services, and helped shape lymphoma research efforts. Dr. Patel was also a member of the Paul G. Allen Research Center at Seattle Cancer Institute, serving as a co-founding member of the Center for Immuno-oncology, where he collaborated on translational research related to immunotherapy in hematologic diseases.Dr. Patel has been published in various medical journals, including New England Journal of Medicine, Blood, and Journal of Clinical Oncology. He is also a member of the ASCO Cancer Communications Committee, the CIBMTR Lymphoma Working Committee, and the National Planning Committee for the Lymphoma Research Foundation Lymphoma Rounds. His clinical and research focus is in lymphomas, CLL, and cellular therapy. Dr. Patel is rated as a Distinguished provider by MediFind in the treatment of Chronic Lymphocytic Leukemia (CLL). His top areas of expertise are Follicular Lymphoma, Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Transplant, and Bone Marrow Aspiration.
Tennessee Oncology PLLC
Jamal Maatouk is an Oncologist and a Hematologist in Nashville, Tennessee. Dr. Maatouk is rated as a Distinguished provider by MediFind in the treatment of Chronic Lymphocytic Leukemia (CLL). Her top areas of expertise are Thrombocytopenia, Paget Disease of the Breast, Adult Immune Thrombocytopenia, and Hemangioma Thrombocytopenia Syndrome. Dr. Maatouk is currently accepting new patients.
Baptist Health Medical Group Inc
Donald Goodin is a Hematologist Oncology specialist and a Hematologist in Elizabethtown, Kentucky. Dr. Goodin is rated as a Distinguished provider by MediFind in the treatment of Chronic Lymphocytic Leukemia (CLL). His top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, and Lung Cancer. Dr. Goodin is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- AgranulocytosisDr. Seshadri isDistinguished. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung CancerDr. Seshadri isDistinguished. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- AnemiaDr. Seshadri isDistinguished. Learn about Anemia.
- AngiosarcomaDr. Seshadri isDistinguished. Learn about Angiosarcoma.
- Breast CancerDr. Seshadri isDistinguished. Learn about Breast Cancer.
- Chronic Familial NeutropeniaDr. Seshadri isDistinguished. Learn about Chronic Familial Neutropenia.
- Advanced
- Adult Immune ThrombocytopeniaDr. Seshadri isAdvanced. Learn about Adult Immune Thrombocytopenia.
- Adult Soft Tissue SarcomaDr. Seshadri isAdvanced. Learn about Adult Soft Tissue Sarcoma.
- Aplastic AnemiaDr. Seshadri isAdvanced. Learn about Aplastic Anemia.
- B-Cell LymphomaDr. Seshadri isAdvanced. Learn about B-Cell Lymphoma.
- Childhood Acute Myeloid LeukemiaDr. Seshadri isAdvanced. Learn about Childhood Acute Myeloid Leukemia.
- ChoriocarcinomaDr. Seshadri isAdvanced. Learn about Choriocarcinoma.
- Experienced
- Acinic Cell Carcinoma of Salivary GlandsDr. Seshadri isExperienced. Learn about Acinic Cell Carcinoma of Salivary Glands.
- Acute Lymphoblastic Leukemia (ALL)Dr. Seshadri isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloblastic Leukemia with MaturationDr. Seshadri isExperienced. Learn about Acute Myeloblastic Leukemia with Maturation.
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Seshadri isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Acute Myelomonocytic LeukemiaDr. Seshadri isExperienced. Learn about Acute Myelomonocytic Leukemia.